Alnylam shares soar after Sanofi buys stake
Alnylam Pharmaceuticals Inc. saw its biggest gain in almost 18 months after Sanofi and its Cambridge-based Genzyme unit agreed to pay $700 million for access to rare-disease treatments and a 12 percent stake in the biotechnology company.
Alnylam rose 41 percent to $93.28 at the close in New York, the biggest single-day gain since July 2012 and its highest value since the Cambridge-based company first offered shares to the public in May 2004.
Genzyme will gain greater access to Alnylam's Patisiran, a therapy for a life-threatening illness that damages the nervous system, as well as the rights to three other drugs, Paris-based Sanofi said in a statement.
Charter Communications offers to buy Time Warner Cable for $62.35B
Charter Communications Inc. has made a verbal offer to buy larger rival Time Warner Cable Inc. for $62.35 billion, including debt.
Charter is offering to pay $132.50 per share — about $83 per share in cash and the rest in its own stock — and is preparing to take its bid to shareholders of Time Warner Cable.
Jim Beam maker acquired by Suntory
The maker of classic American bourbon whiskey Jim Beam, Beam Inc., has been acquired by Japanese spirits giant Suntory Holdings for $13.6 billion in cash, the companies announced yesterday. Including the assumption of Beam's outstanding debt, the deal is valued at $16 billion and very well could create a new global leader in spirits and whiskey.
Suntory, which was founded in 1899, is a privately-held company known for producing Japan's first whiskey.
Today
Commerce Department releases retail sales data for December.
Commerce Department releases business inventories for November.
TOMORROW
Labor Department releases the Producer Price Index for December.
Federal Reserve releases Beige Book.
THE SHUFFLE
Murphy & King P. C. announced today that Elizabeth A. Murphy, left, has joined the law firm as a litigation associate in the firm's business litigation practice. Murphy will concentrate her practice on complex business and commercial litigation matters.
Health Plan of Massachusetts, a wholly owned subsidiary of Centene Corp., announced the appointment of Jay Gonzalez as president and chief executive officer. He served as senior vice president and chief development officer of CeltiCare Health for the past nine months.
Anda sedang membaca artikel tentang
The Ticker
Dengan url
http://bintanggugel.blogspot.com/2014/01/the-ticker_14.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
The Ticker
namun jangan lupa untuk meletakkan link
sebagai sumbernya
0 komentar:
Posting Komentar